Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 1, 2007, Pages 144-151

  Oweida, Ayman J ^a   Dunn, Elizabeth A ^a   Karlik, Stephen J ^a   Dekaban, Gregory A ^a   Foster, Paula J ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Cell tracking; Cellular imaging; EAE; Macrophages; Magnetic resonance imaging; Superparamagnetic iron oxide

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FERRIC FERROCYANIDE; SUPERPARAMAGNETIC IRON OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL LINEAGE; CONTROLLED STUDY; FAST IMAGING EMPLOYING STEADY STATE ACQUISITION; FEMALE; IMAGE ANALYSIS; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; TRANSGENIC MOUSE;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; OXIDES; REPRODUCIBILITY OF RESULTS;

EID: 34547797893     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21005     Document Type: Article

References (40)

1. Ewing C, Bernard CC. Insights into the etiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998;76:47-54.
2. Morales Y, Parisi JE, Lucchinetti CF. The pathology of multiple sclerosis: evidence for heterogeneity. Adv Neurol 2006;98:27-45.
3. Smith E. Phagocytosis of myelin in demyelinative disease: a review. Neurochem Res 1999;24:261-268.
4. Petry KG, Boullerne AI, Pousset F, Brochet B, Caille JM, Dousset V. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis. Pathol Biol 2000;48:47-53.
5. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000;6:88-91.
6. Minagar A, Alexander JS. Blood-brain barrier disruption in MS. Mult Scler 2003;9:540-549.
7. Tanaka R, Iwasaki Y, Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975;81:467-478.
8. Bernard CCA, Leydon J, Mackay IR. T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol 1976;6:655-660.
9. Bruck W, Sommermeier N, Bergmann M, et al. Macrophages in multiple sclerosis. Immunobiology 1996;195:588-600.
10. Benveniste EN. Role of macrophages/microglia in MS and EAE. J Mol Med 1997;75:165-173.
11. Eng LF, Ghirnikar RS, Lee YL. Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 1996;21:511-525.
12. Piraino PS, Yednock TA, Freedman SB, et al. Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin. J Neuroimmunol 2002;131:147-59.
13. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-1033.
14. Kent SJ, Karlik SJ, Cannon C, et al. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:1-10.
15. Polfliet MM, van de Veerdonk F, Dopp EA, et al. The role of perivascular and meningeal macrophages in EAE. J Neuroimmunol 2002;22:1-8.
16. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 1988;239:290-292.
17. Smith M. Phagocytic properties of microglia in vitro: implications for a role in MS. Microsc Res Tach 2001;54:81-94.
18. Weissleder R, Cheng H-C, Bogdanov A, Bogdanov Jr A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-263.
19. Modo M, Hoeh M, Bulte JWM. Cellular MR imaging. Mol Imaging 2005;4:143-164.
20. Pirko I, Ciric B, Johnson AJ, Gamez J, Rodriguez M, Macura S. MRI of immune cells in inflammation of central nervous system. Croat Med J 2003;44:463-468.
21. Moore A, Marecos E, Bogdanov Jr A, Weissleder R. Tumoral distribution of long circulating dextran coated iron oxide nanoparticles in a rodent model. Radiology 2000;214:568-574.
22. Kanno S, Wu YJ, Lee PC, et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by MRI with USPIO. Circulation 2001;104:934-938.
23. Wadghiri YZ, Sigurdsson EM, Sadowski M, et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293-302.
24. Dunn EA, Dekaban GA, Weaver LC, Foster PJ. Cellular imaging of inflammation after spinal cord injury. Mol Imaging 2005;4:1-10.
25. Heyn C, Ronald JA, Mackenzie LT, et al. In vivo MRI of single cells in mouse brain with optical validation. Magn Reson Med 2006;55:23-29.
26. Lee IH, Bulte JW, Schweinhardt P, et al. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol 2004;187:509-516.
27. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM. Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA 1999;8:185-189.
28. Dousset V, Delalande C, Ballarino L, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999;41:329-333.
29. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. MRI of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004;55:654-659.
30. Rausch M, Hiestad P, Baumann D, Cannet C, Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 2003;50:309-314.
31. Xu S, Jordan EK, Brocke S, et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 1998;52:549-558.
32. Wang YXJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331.
33. Oweida AJ, Dunn EA, Foster PJ. Cellular imaging at 1.5T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide. Mol Imaging 2004;3:85-95.
34. Dousset V, Brochet B, Deloire MSA, et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol 2006;27:1000-1005.
35. Faust N, Varas F, Kelly LM, Heck S, Graf T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 2000;96:719-726.
36. Costa O, Divoux D, Ischenko A, Tron F, Fontaine M. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG35-55 peptide in C57BL6/J strain of mice. J Autoimmunity 2003;20:51-61.
37. Tran EH, Kuziel WA, Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1a or its CCR5 receptor. Eur J Immunol 2000;30:1410-1415.
38. Foster-Gareau PJ, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5T clinical MRI scanner. Magn Reson Med 2003;49:968-971.
39. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold for single SPIO labeled cells with FIESTA. Magn Reson Med 2005;53:312-320.
40. Muldoon LL, Pagel MA, Kroll RA, Roman-Goldstein S, Jones RS, Neuwalt EA. A physiological barrier distal to the anatomical blood-brain-barrier in a model of transvascular delivery. AJNR Am J Neuroradiol 1999;20:217-222.